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A investigação fitoquímica do extrato etanólico do caule de Senna martiana Benth.
(Leguminoseae), espécie nativa do nordeste do Brasil, permitiu o isolamento e caracterização 
espectroscópica de uma biantrona inédita denominada martianina (1), 10,10’-H-bicrisofanol-
10-ox-10,10’-biglucosil. Sua identificação estrutural inequívoca foi estabelecida por HRMS, IV 
e RMN de 1H e 13C uni e bi-dimensional. A atividade tripanocida de martianina foi avaliada por 
seu comportamento frente à enzima GAPDHTc através da obtenção de sua constante de inibição 
(Ki) determinada por titulação calorimétrica isotérmica (27,3 ± 2,47 µmol L-1). Estes resultados 
sugerem que esta classe de molécula tem potencial no desenvolvimento de novos fármacos a serem 
utilizados contra a doença de Chagas.
A phytochemical investigation of the ethanolic extract of stalks of Senna martiana Benth.
(Leguminoseae), native specie of northeast Brazil, resulted in the isolation and spectroscopic 
characterization of a new bianthrone glycoside, martianine 1 (10,10’-il-chrysophanol-10-oxi-
10,10’-bi-glucosyl). Its identification was established by HRMS, IR and 2D NMR experiments. 
The evaluation of martianine trypanocidal activity was carried out against gliceraldehyde 
3-phosphate dehydrogenase enzyme from Trypanosoma cruzi. Its inhibitory constant (Ki) is in 
the low micromolar concentration and it was determined by isothermal titration calorimetry to 
be 27.3 ±2.47 µmol L-1. The non-competitive mechanism is asserted to be putative of the mode 
of action martianine displays against T. cruzi GAPDH. Results show that martianine has a great 
potential to become new lead molecule by inhibiting this key enzyme and for the development of 
new drugs against Chagas disease.
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Introduction
Senna martiana (Benth) I&B (Leguminoseae), is a 
native specie of northeast Brazil and it is a shrub presenting 
abundant foliages and exuberant yellow flowers. This 
plant is locally known as “canafístula brava” and “caixão 
de canafístula”.1 Previous chemical studies do not exist 
about S. martiana but others species of the genus Senna, 
have shown to be in great occurrence of anthraquinone 
compounds, isolated from several parts of the plant 
with less incidence in the leaves.2,3 The anthraquinone 
compounds are distributed widely in the nature, mainly 
as being responsible for the pigmentation and are found 
in fungi, superior plants and lichens.4 There are reports 
of several biological activities attributed to the presence 
of anthraquinones such as antioxidant, laxative, antiviral, 
antimicrobial and trypanocidal.5-9 
Chagas disease (also called American Trypanosomiasis) 
is caused by the flagellate protozoa Trypanosoma cruzi. It 
is estimated that 16-18 million people are infected in 18 
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countries of Latin America and in the US 100,000-675,000 
immigrants from Latin America are infected with T. cruzi. 
It is one of the most neglected diseases in the world and 
lack of financial support is one of the major characteristic 
avoiding the fulfillment of proper investigations. At 
present, the available drugs nifurtimox (Lampit™, 
Bayer) and benznidazole (Rochagan™, Radanil™, 
Roche) have strong side effects along with low efficacy 
in addition of being used only in the acute stage of the 
disease.10,11
New molecules with trypanocidal activity are 
scarce and most of them have low affinity for their 
biochemical targets. Among the available targets claimed 
to be of importance in the search for inhibitors is the 
gliceraldehyde-3-phosphate dehydrogenase (GAPDH), an 
enzyme of the T. cruzi glycolytic pathway. Although there 
is a growing interest in GAPDH as trypanocidal target 
against T. cruzi, a literature survey of known GAPDH 
inhibitors reveals none identified to date by Aronov et al.,12 
Tomazela et al.,13 De Marchi et al.14 and Ladame et al.15 
Thus, the need for discovering inhibitors to act against 
T. cruzi glicossomal GAPDH of interest in the Chagas 
disease has stimulated our group to begin a structure-based 
drug design study using isothermal titration calorimetry 
(ITC). In doing so, the discovery of new trypanocidal lead 
compounds can be dealt with.16
In the present work, we describe the isolation and 
structural elucidation of a new bianthron glycoside for 
us dubbed martianine (1) from stalks of Senna martiana 
Benth. Its spectroscopic 1H and 13C NMR data with 2D 
NMR experiments (1H-1H COSY, HSQC, and HMBC) 
confirmed the proposed structure. Its activity against T. cruzi 
was evaluated by isothermal titration calorimetry using the 
enzyme glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) as a potential target.
Experimental
General
IR spectra were recorded on Perkin Elmer, model 
FT-IR Spectrum 1000. NMR spectra were obtained on a 
Bruker, DPX-500 instrument operating at 500 MHz for 
1H and 125 MHz for 13C. Chemical shifts (d) are reported 
in ppm using solvent signal as the internal standard. 1H-, 
13C-NMR, DEPT-135 (to determine carbon multiplicities) 
spectra were recorded, as well as two-dimensional NMR 
spectra: COSY to investigate 1H-1H correlations, HSQC 
for one-bond 13C-1H correlations, and HMBC for a 
long-range 13C-1H correlations. Two-dimensional NMR 
experiments were carried out using pulsed field gradients. 
Mass spectra were recorded on an ultrOTOFQ ESI-TOF 
Mass Spectrometer, instrument of Bruker Daltonics, 
Billerica, MA, EUA, under the following conditions: 
infusion pump, flow 300 µL h-1, NA-TFA at 10 mg mL-1 
was used for internal calibration and HCO2Na 10 mmol L-1 
for external calibration.
Plant material
The stalks of S. martiana was collected at in Apodi 
plateau, Rio Grande do Norte State, Brazil in May 2003, 
and identified by Prof. Edson de Paula Nunes of the Biology 
Department, University Federal of Ceará (UFC). A voucher 
specimen (32440) has been deposited in the Herbarium of 
Biology Department-UFC, Fortaleza, CE, Brazil.
Extraction and isolation
Air-dried powdered stem of S. martiana (3020 g) was 
exhaustively extracted with EtOH by maceration. The 
extract was concentrated under vacuum to afford 70 g 
residue and was chromatographed on sand (60 mesh) 
previously treated. The measurements of the used column 
were of 8.0 cm of diameter for 60.0 cm of height, the 
amount of used fixed phase was of 500 g. Using C6H14, 
CH2Cl2, EtOAc, MeOH as movable phase, where was 
collected 11 fractions of 125 mL each. The CH2Cl2 fraction 
(10.7 g) was purificated using 130 g of silica gel (VETEC, 
φ mm 0.063-0.200) in a chromatographic column of 5.0 cm 
of diameter for 50 cm of height and using a gradient of 
increasing polarity of C6H14, CH2Cl2, EtOAc and MeOH 
pure or in binary combinations. The combinations had 
observed the following ratio: 1:0, 4:1, 1:1, 1:4 and 0:1 and 
for each mobile phase used, 5 fractions of 50 mL had been 
collected. Fractions thus collected were analyzed through 
CCD on silica gel (Sigma Chemical CO, φ µm 2-25). 
Spots were detected under UV (254 and 356 nm), vanillin-
sulfuric acid was used as a standard spraying reagent and 
plates were heated in an oven at 110 °C for 5 minutes. The 
fractions gotten from the eluents CH2Cl2:EtOAc (1:4) and 
pure EtOAc, had been mixed (715 mg), in accordance with 
the similarity present for CCD. This material was purified 
by column chromatography on silica gel (VETEC, φ mm 
0.063-0.200) using C6H12 –CH2Cl2 (100:0, 1:1 and 0:100) 
and CH2Cl2-EtOAc (4:1, 1:1, 1:4 and 0:1) in a column 
of 3.0 cm of diameter for 40.0 cm of height, using 50 g 
of silica gel. The fractions were collected in a volume of 
10 mL in a total of 65 fractions each. The fractions 28-34, 
gotten from CH2Cl2:EtOAc (1:4 and 0:1), gave 36 mg of 
compound 1 presenting as solid dark orange (bianthron 
glycoside, martianine).
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10,10’-il-chrysophanol-10-oxi-10,10’-bi-glucosyl 
(Martianine 1) 
[α]D25: (c 1.0 mg mL-1, acetone); dark orange solid, acetone, 
168.2-170.1 °C, 1H-NMR (500 MHz, acetone-d6, d), 13C NMR 
(125 MHz, acetone-d6, d): see Table 1.
Isothermal titration calorimetry and enzyme kinetics 
All titration experiments were carried out using 
an Isothermal Titration Calorimetry instrument (VP-
ITC, MicroCal, Northampton, USA).17 Reaction cells 
(1.43 mL) were filled with solutions and equilibrated 
at 25 oC. After this equilibration, an additional delay 
period was allowed to generate the baseline used in the 
subsequent data analyses. All solutions were degassed 
by use of a vacuum degasser (ThermoVac, MicroCal) 
for 5 min prior to any experimental run. Stirring speed 
was maintained at 307 rpm and heat-flow (µcal s-1) was 
recorded as a function of time.
Enzyme assays
Expression and purification of the glycossomal 
Trypanosoma cruzi  gliceraldehyde-3-phosphate 
dehydrogenase GAPDH (EC 1.2.1.12) were carried out 
as described previously.18 The concentration of GAPDH 
after the dialysis against TEA buffer was determined 
by Bradford Method,19 glycerol 10% v/v was added in 
the solution at the final concentration of 2 µmol L-1 and 
stocked at –80 ºC. Isothermal titration experiments were 
carried out with stock solutions of GAPDH in glycerol 
kept at −80 oC. The solution was diluted to final enzyme 
concentration of 5.0 nmol L-1. The concentration of glycerol 
was negligible after stock solution dilution, since only 
5 µL of the stock solution was mixed with 2.0 mL enzyme 
reaction buffer and no significant change in the instrument 
thermal power was observed. The D,L-glyceraldehyde-
3-phosphate (G3P), TEA-HCl, β-mercaptoethanol, 
NaHAsO4•7H2O, NAD+, DMSO (99.9%) and methanol 
(99.9) were purchased from Sigma (USA). GAPDH 
normally forms 1,3-diphosphoglycerate when phosphate is 
present. Arsenate is the substitute for phosphate in this study 
reaction for minimizing the enzyme product inhibition. 
The enzyme GAPDH was dialyzed against a solution of 
TEA-HCl buffer pH 7.5 0.1 mol L-1, β-mercaptoethanol 
1.0 mmol L-1, NaHAsO4•7H2O, 30 mmol L-1 and NAD+ 
1.5 mmol L-1. Due to stability, activity and reproducibility 
of the assays not seen in other buffered solutions like 
Tris-HCl and phosphate the TEA-HCl was elected to be 
the choice for all experiments being carried out using this 
stock solution. 
The multiple injection method was chosen due presence 
of product inhibition.20 There are two fundamentally 
different calorimetric approaches: single injection and 
multiple injection assay. The advantage of the latter 
approach is that the amount of product formed is negligible. 
Hence, it is assured that product inhibition does not 
significantly influence the measurements (see references 
3 and 4 for more details on these methods).
The apparent enthalpy (∆H
app) of conversion of G3P 
to 1-arseno-3-phosphoglycerate was determined by filling 
the sample cell with the D,L-glyceraldehyde-3-phosphate 
(G3P) 1.0 mmol L-1, TEA-HCl buffer pH 7.5 0.1 mol L-1 
β-mercaptoethanol 1.0 mmol L-1, NaHAsO4•7H2O 
30.0 mmol L-1 and NAD+ 1.4 mmol L-1. The syringe was 
loaded with the enzyme 1 µmol L-1 in the same cell solution 
and titrated by an injection of 10 µL; the final enzyme 
concentration in the cell was 7 nmol L-1. The complete 
G3P depletion was observed making the reaction come to 
an end and the instrumental thermal power returned to the 
initial baseline. The dilution of the enzyme was determined 
at same experimental conditions, in absence of G3P. The 
integration of the area under the curve for enzyme assay, 
after subtracted on the dilution heat, gives the value of ∆H
app 
obtained for all biochemical reactions. 
In the kinetic assays the sample cell was loaded with 
GAPDH 5 nmol L-1, TEA-HCl buffer pH 7.5 0.1 mol L-1, 
β-mercaptoethanol 1.0 mmol L-1, NaHAsO4•7H2O, 
30 mmol L-1, NAD+ 1.4 mmol L-1 and DMSO 5.0% v/v. 
The experiments were carried out in absence of martianine 
and presence of 50 µmol L-1 for inhibition enzyme assay. 
The syringe was loaded with G3P (5 mmol L-1) in the 
same buffer solution as for the one in the sample cell and 
titrated by 25 injections of 4 µL each. The interval between 
each injection was 60 s. Under these conditions, it was not 
observed any significant product inhibition.
Data analysis
Analyses of the raw data were performed with Origin 
version 7.0 software.21 To carry out the calculations, the data 
representing the heat effects due to substrate dilution into 
buffer and mixing were subtracted from the heat-flow raw 
data. The remaining data represent the reaction progress 
curve, which were analyzed in Enzyme Assay mode in Origin 
software. Kinetic parameters (KM and kcat) as well as the 
apparent enthalpy (∆H
app) for the reaction of G3P conversion 
to 1-arseno-3-phosphoglycerate were also calculated 
by use of Origin version 7.0 software. The inhibition 
constant (Ki) was obtained by nonlinear least-squares fit 
of the experimental data to the non-competitive inhibition 
Michaelis-Menten equation in SigmaPlot 9.0 software. 
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Results and Discussion
Martianine (1)
Compound 1 was isolated as a dark orange pigment and 
identified from the ethanolic extract stem S. martiana. Its 
molecular formula C42H42O16 was established by HRMS 
[m/z 859 (M + H2O + Na+)]. The IR spectrum showed 
a broad band at 3401 cm-1 for free OH groups, aromatic 
system at 1609, 1487 and 1452 cm-1 and a sharp (C=O 
stretch) peak at 1638 cm-1. The structure was deduced from 
detailed analysis of 1H and 13C NMR data aided by mean of 
2D NMR experiments (1H-1H COSY, HSQC, and HMBC) 
(Table 1). The character dimeric is observed in the spectrum 
of 1H NMR and 13C NMR, because all the signs appear in 
a duplicated way. In the NMR 1H spectrum, the signals at 
d 3.1-3.5 was suggested to be attributed to the sugar groups 
present in martianine structure. Ten signals in the region of 
d 6.7-7.6 indicated the presence of system aromatic. The 
NMR 13C spectrum confirms the aromatic character of the 
compound in question for the presence of the signals in 
the region of d 115.1-162.5, of these four they are of the 
oxygenated type, what is proven for your displacement, 
region of d 162.2-162.9, due to your character dimeric, 
we have then one system aromatic type anthraquinonic 
Table 1. 1H and 13C NMR data of the 2D NMR experiments (1H-1H COSY, 
HSQC, and HMBC) of martianine
Position dC dH HMBC
2JCH 3JCH
                 ( C )
1 162.5 - H-2
1’ 162.9 - H-2’
3 148.9 - Me-3; H-4
3’ 148.1 - Me-3’
4a 146.5 - H-4 H-1’’
4’a 146.5 - H-1’’’
8 162.6 - H-6
8’ 162.2 - H-6
8a 117.5 - H-5; H-7
8’a 117.3 - H-5’; H-7’
9/9’ 194.3 -
9a 115.1 - H-2; H-4
9’a 115.3 - H-2’; H-4’
10 76.8 - H-1’’ H-4; H-5; 
H-2’’
10’ 76.8 - H-1’’’ H-4’; H-5’; 
H-2’’’
10a 149.0 - H-6; H-1’’
10’a 149.1 - H-5’ H-6’’; H-1’’’
2 117.7 6.74(s) Me-3; H-4
2’ 117.9 6.75 (s) Me-3’; H-4’
4 118.9 7.36 (s) Me-3; H-2
4’ 120.1 7.27 (s) Me-3’; H-2’
5 118.8 7.4 (dd, J 7.6 and 0.7 Hz) H-7
5’ 117.6 7.5 (dd, J 7.6 and 0.7 Hz) H-7’
6 136.2 7.6 (t, J 7.6 Hz) H-5; H-7
6’ 136.9 7.6 (t, J 7.6 Hz) H-5’
7 118.0 6.9 (d, J 7.6 Hz) H-5
7’ 118.0 6.9 (d, J 7.6 Hz) H-5’
Me-3 22.5 2.4 (s) H-2; H-4
Me-3’ 22.5 2.4 (s) H-2’; H-4’
1’’ 84.5 3.3 (d, J 9.4 Hz) H-2’’ H-3’’
2’’ 72.9 3.1 (t, J 9.4 Hz) H-1’’; H-3’’ H-4’’
3’’ 79.3 3.4-3.3 (m) H-2’’; H-4’’ H-1’’
4’’ 71.8 3.0-2.9 (m) H-5’’ 2H-6’’
5’’ 81.1 3.0-2.9 (m) H-4’’; 2H-6’’ H-1’’
6’’ 63.3 3.6 (dd, J 11.3 and 
2.6 Hz); 3.4 (m)
H-5’’ H-4’’
1’’’ 84.5 3.3 (d, J 9.5 Hz) H-2’’’ H-3’’’
2’’’ 72.9 3.1 (t, J 9.5 Hz) H-1’’’, H-3’’’ H-4’’’
3’’’ 79.4 3.4-3.3 (m) H-2’’’; H-4’’’ H-1’’’
4’’’ 71.8 3.0-2.9 (m) H-5’’’ 2H-6’’’
5’’’ 81.0 3.0-2.9 (m) H-4’’’; 2H-6’’’ H-1’’’
6’’’ 63.3 3.5 (dd, J 11.3 and 
2.6 Hz); 3.4 (m)
H-5’’’ H-4’’’
Figure 1. HMQC correlations observed in NMR spectrum.
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1.8-dihydroxyl. The other sign d 22.5 that shows the 
presence of a methyl probably linked to the aromatic 
ring. Summarizing, the 13C NMR data indicated that the 
molecule presented two carbonyls (d 194.3), twenty-four 
aromatic carbons (d 115.1-162.9), twelve sugar carbons (d 
63.3-84.5), and two methyl groups (d 22.5). The absence 
of a signal near d 180, that it would be corresponding to 
another one carbonyl is in accordance with the anthron and 
affords the presence of a characteristic group as belonging 
to the scaffold of the compound in question. 
This martianine structure is the product of the 
condensation of two molecules of 10-hydroxy-10-
glucosyl-chrysophanolanthron, its dimeric character was 
confirmed by the presence of the signals duplicates in the 
NMR 1H and 13C spectra and for its molecular mass of 
m/z 802, what it is in accordance with the total mass of 
two molecules of glucosyl-chrysophanolanthrons. The 
2D NMR spectroscopic techniques had confirmed the 
assignments above cited and the presence of one unit 
of glucose to carbon 10, that it can be established by 
HMQC correlations of H-1’’ to C-10, H-2’’ to C-10, H-1’’ 
to C-5’’, H-2’’ to C-3’’, H1-6’’ to C-5’’, H2-6’’ to C-5’’ 
(Figure 1), which proves the connection of the chain of 
the sugar and C-10 anthron. The absence of the signal at 
about d 101.00 referring to anomeric carbon is not present, 
thus allowing concluding that the compound presents 
deoxy glucose in its structure. Long-range correlations 
in HMBC spectrum showed that at as correlations H-2 
to C-1, H- 4 to C-3, H-6 to C-8, H-7 to C-6, H-7 to C-8 
confirming the skeleton anthron for this compound. The 
long-range correlations H-4/H-5/H-2’’ to C-10 (Figure 
2) and H-4’/H- 5’/H-2”’ to C-10’ confirm the position in 
C-10 of side chain of sugar.
The conversion rates of glyceraldehyde-3-phosphate 
to 1-arseno-3-phosphoglycerate catalyzed by T. cruzi 
GAPDH in solutions of TEA buffer were monitored via 
ITC. The experiments were carried out in presence and 
absence of martianine and results can be found in Figure 3. 
The exothermic sharp peaks that can be seen in Figure 3A 
represent the heat of dilution for all injections. Among the 
peaks, the heat released from substrate depletion takes 
place at the steady state and the instrumental thermal power 
remains constant. There is a change in the steady state heat-
flow as the reaction rate increases after each injection. This 
keeps going until the baseline reaches the final steady state 
Figure 2. Long-range correlations in HMBC spectrum.
Figure 3. (A) Typical raw data for thermal power change as a function of 
time in the multiple injections assay and (B) Nonlinear least-squares fit of 
experimental data (dotted line) to Michaelis-Menten equation to determine 
kinetic parameters. Experiment control () and presence of 50 µmol (), 
25 injections of G3P 5.0 mmol L-1 were titrated into the sample cell filled 
with the GAPDH buffered solution. Michaelis-Menten curve was plotted 
and data points were truncated when the reaction reached the maximum 
velocity. Under these conditions, product inhibition was thoroughly 
avoided. ∆H
app = −5.76 Kmol used for rate calculus was determined in a 
separate experiment.
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heat-flow level. The dependence of the reaction rate on 
glyceraldehyde-3-phosphate concentration follows typical 
Michaelis-Menten kinetics mechanism. The parameters k
cat 
and KM were obtained by fitting the raw data points to the 
Michaelis-Menten equation, using non-linear regression, 
and results can be seen in Table 2.
The results depicted in Table 2 and Figure3 suggest that 
the GAPDH enzyme is inhibited by martianine in a non-
competitive mechanism. The value of Michaelis-Menten 
constant (KM) does not change during the experiments and 
the catalytic constant (k
cat) diminishes at no KM expenses, 
as compared to control experiments. The stocked enzyme 
shows a loss of activity in function of the storage time. 
Nevertheless, when a control experiment is carried 
out previously to each inhibition assay the determined 
inhibition constant (Ki) is reproducible. As can be seen 
in Table 1 even with the change in the k
cat (experiments 
realized in different days) the Ki was still the same.
The enzyme glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) plays an important role in the life cycle of the 
Trypanosoma cruzi and it has become an important target 
in the drug discovery for Chagas disease.22 The high 
martianine affinity for the GAPDH it agrees to the some 
anthraquinones have shown activity against the parasite.5,23 
The potential isothermal titration calorimetry has in the 
search for new inhibitors are thus put forward. It provides 
a direct measure of small molecule binding to enzymes as 
molecular targets in the drug discovery and development. 
The relationship of kinetic parameters to the drug-receptor 
interactions allows a fast description of substrate binding. 
The contribution to GAPDH catalysis is easily accounted 
for all processes taking place during the conversion to 
product. The catalytic efficiency of GAPDH enzyme entails 
the shape complementarities between enzyme and transition 
state. The catalytic efficiency (k
cat/KM 107mol L-1s-1) 
for the first control experiment is 1.4 whereas it comes to 
0.9 when the second control experiment is carried out. In 
the presence of martianine the first measurement results 
in the catalytic efficiency to be 1.2, and it comes down to 
0.8 in the second one. Thus, the martianine small molecule 
does not enhance the catalytic efficiency of GAPDH. On 
the contrary, it reduces the overall catalytic efficiency so 
indicating the diminution of the k
cat not at the expenses of 
KM that remains thoroughly constant. Overall, despite the 
change in the catalytic efficiency due to GAPDH loosing 
its activity this is not accounted for when the inhibitory 
constant is to be determined via isothermal titration 
calorimetry. 
Conclusions
Martianine 1 is a of a new bianthrone glycoside isolated 
from Senna martiana Benth and the high martianine affinity 
for the GAPDHTc enzyme suggests that this molecular class 
may be useful for the development of new drugs against 
Chagas disease. 
Supplementary Information
Supplementary data of martianine structure as 1 and 
2D 1H and 13C NMR spectra are available free of charge at 
http://jbcs.sbq.org.br, as PDF file.
Acknowledgments
Authors acknowledge to Dr. N. P. Lopes (FCFRP, 
Universidade de São Paulo) for recording the mass spectra 
and also acknowledge to CNPq, FUNCAP and FAPESP 
for financial support. 
References
 1.  Irwin, H. S.; Barneby, R. C.; Memoirs of the New York Botanical 
Garden; The American Cassiinae: A Synoptical Revision of 
Leguminosae Tribe Cassieae, subtribe Cassiinae in the New 
World, Vol. 35, Part 1, The New York Botanical Garden Press: 
New York, 1982, p. 465.
 2.  Barbosa, F. G.; Oliveira, M. C. F.; Braz-Filho, R.; Silveira, E. 
R.; Biochem. Syst. Ecol. 2004, 32, 363.
 3.  Alemayehu, G.; Abegaz, B.; Kraus, W. A.; Phytochemistry 1998, 
48, 699.
 4.  Koyama, J.; Morita, I.; Tagahara, K.; Aqil, M.; Phytochemistry 
2001, 56, 849.
 5.  Mbwambo, Z. H.; Apers, S.; Moshi, M. J.; Kapingu, M. C.; Van 
Miert, S.; Claeys, M.; Brun, R.; Cos, P.; Pieters, L.; Vlietink, 
A.; Planta Med. 2004, 70, 706. 
 6.  Vila, J. L.; Mollinedo, P.; Sterner, O.; Rev. Bol. Quim. 2003, 
20, 49.
 7.  Pivatto, M.; Crotti, A. E. M.; Lopes, N. P.; Castro-Gamboa, 
I.; Rezende, A.; Viegas Jr., C.; Young, M. C. M.; Furlan, M.; 
Bolzani, V. S.; J. Braz. Chem. Soc. 2005, 16, 1431.
Table 2. Kinetic parameters kcat, KM (observed values from curves in 
Figure 3) and Ki of the martianine
k
cat / (s-1) KM / (µmol L-1) Ki / (µmol L-1)
Control 1 177 (±2) 11.8 (±0.7) -
Martianine 1 156 (±3) 10.6 (±1.0) 28.4 (±0.5)
Control 2 117 (±1) 12.5 (±1.1) -
Martianine 2 105 (±1) 14.6 (±0.4) 26.2 (±0.9)
Average values 12.4 (±1.7) 27.3 (±1.6)
de Macedo et al. 953Vol. 20, No. 5, 2009
 8.  Silva, G. H.; Teles, H. L.; Trevisan, H. C.; Bolzani, V. S.; 
Young, M. C. M.; Pfenning, L. H.; Eberlin, M. N.; Haddad, R.; 
Costa-Neto, C. M.; Araújo, A. R.; J. Braz. Chem. Soc. 2005, 
16, 1463.
 9.  Sepúlveda-Boza, S.; Cassels, B. K.; Planta Med. 1996, 62, 
98.
 10.  Coura, J. R.; Castro, S. L.; Mem. Inst. Oswaldo Cruz 2002, 97, 
3. 
 11.  Campo, V. L.; Carvalho, I.; Allman, S.; Davis, B. J.; Field, R. 
A.; Org. Biomol. Chem. 2007, 5, 2645.
 12.  Aronov, A. M.; Suresh, S.; Buckner, F. S.; Van Voorhis, W. C.; 
Verlinde, C. L. M. J.; Opperdoes, F. R.; Hol, W. G. J.; Gelb, M. 
H.; Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 4273.
 13.  Tomazela, D. M.; Pupo, M. T.; Passador, E. A. P.; Silva, M. F. 
G. F.; Vieira, P. C.; Fernandes, J. B.; Rodrigues, E. F.; Oliva, 
G.; Pirani, J. R.; Phytochemistry 2000, 55, 643.
 14.  De Marchi, A. A.; Castilho, M. S.; Nascimento, P. G. B.; 
Archanjo, F. C.; Del Ponte, G.; Oliva, G.; Pupo, M. T.; Bioorg. 
Med. Chem. 2004, 12, 4823.
 15.  Ladame, S.; Fauré, R.; Denier, C.; Lakhdar-Ghazal, F.; Willson, 
M.; Org. Biomol. Chem. 2005, 3, 2070.
 16.  Liñares, G. E. G.; Ravaschino, E. L.; Rodriguez, J. B.; Curr. 
Med. Chem. 2006, 13, 335.
 17.  Wiseman, T.; Williston, S.; Brandts, J. F.; Lin, L. N.; Anal. 
Biochem. 1989, 179, 131.
 18.  Hannaert, V.; Opperdoes, F. R.; Michels, P. A. M.; Protein 
Expression Purif. 1995, 6, 244.
 19.  Bradford, M. M.; Anal. Biochem. 1976, 72, 248.
 20.  Wiggers, H. J.; Cheleski, J.; Zottis, A.; Oliva, G.; Andricopulo, 
A. D.; Montanari, C. A.; Anal. Biochem. 2007, 370, 107.
 21.  ITC Data Analysis in Origin®, Tutorial Guide, Version 7.0, 
MicroCal, LLC: Northampton, MA, 2004.
 22.  Souza, D. H. F.; Garratt, R. C.; Araújo, A. P. U.; Guimarães, B. 
G.; Jesus, W. D. P.; Michels, P. A. M.; FEBS Lett. 1998, 424, 
131.
 23.  Cuellar, M. A.; Salas, C.; Corte´s, M. J.; Morello, A.; Maya, J. 
D.; Preite, M. D.; Bioorg. Med. Chem. 2003, 11, 2489. 
Received: March 3, 2008
Web Release Date: April 24, 2009
FAPESP helped in meeting the publication costs of this article.
Supplem
entary Inform
ation
J. Braz. Chem. Soc., Vol. 20, No. 5, S1-S2, 2009.
Printed in Brazil - ©2009  Sociedade Brasileira de Química
0103 - 5053  $6.00+0.00
*e-mail: mgvsilva@ufc.br
A New Bianthron Glycoside as Inhibitor of Trypanosoma cruzi Glyceraldehyde  
3-Phosphate Dehydrogenase Activity
Edângelo M. S. de Macedo,a Helton J. Wiggers,b Maria G. V. Silva,*,a,b Raimundo Braz-Filho,c  
Adriano D. Andricopulod and Carlos A. Montanarib
aDepartamento de Química Analítica e Físico-Química, Departamento de Química Orgânica e Inorgânica,  
Universidade Federal do Ceará, 60455-970 Fortaleza-CE, Brazil
bInstituto de Química de São Carlos and dInstituto de Física de São Carlos, Universidade de São Paulo,  
13560-970 São Carlos-SP, Brazil
cSetor de Química de Produtos Naturais, CCT, Universidade Estadual do Norte Fluminense,  
28013-602 Campos dos Goytacazes-RJ, Brazil
Figure S1. 1H NMR  spectrum of martianine.
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Figure S2. 13C NMR spectrum of martianine.
